LAWSUITS NEWS & LEGAL INFORMATION
GlaxoSmithKline.
A $75 million settlement has been reached in the consumer lawsuit filed regarding charges that the company illegally blocked generic versions of its arthritis drug Relafen in the United States. (May-24-04) [FORBES]
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no obligation, please click the link below to submit your complaint.Published on Jul-9-04